in this study we evaluated 77 patients with superficial bladder cancer who were treated with either intravesical bacillus calmette-guerin ( bcg ) ( 44 patients ) or doxorubicin hydrochloride ( adriamycin , adr ) ( 33 patients ) for prophylaxis of tumor recurrence after transurethral resection .
C0546861
doxorubicin hydrochloride
C0085752
adriamycin